Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
HEALTHEQUITY, INC. amended revolving credit with JPMorgan Chase Bank, N.A., as administrative agent at Term SOFR, plus a 0.10% credit spread adjustment, plus a margin ranging from 1.2.
- Instrument
- revolving credit
- Counterparty
- JPMorgan Chase Bank, N.A., as administrative agent
- Rate
- Term SOFR, plus a 0.10% credit spread adjustment, plus a margin ranging from 1.2
- Event
- amendment
Exact text from the filing
On June 1, 2023, HealthEquity, Inc. (the “Company”) entered into an Amendment No. 1 to Credit Agreement (“Amendment No. 1”), which amends that certain Credit Agreement, dated as of October 8, 2021 (the “Credit Agreement”), among the Company, as borrower, each lender from time to time party thereto, JPMorgan Chase Bank, N.A., as administrative agent and the Swing Line Lender (as defined therein), and each L/C Issuer (as defined therein) party thereto. The provisions of Amendment No. 1 replaced interest rate provisions based on the London interbank offered rate (“LIBOR”) in the Credit Agreement with the forward-looking term rate based on the secured overnight financing rate published by the CME Group Benchmark Administration Limited (“Term SOFR”). As a result, borrowings under the Credit Agreement as so amended by Amendment No. 1 will bear interest at an annual rate equal to, at the option of the Company, either (i) Term SOFR, plus a 0.10% credit spread adjustment, plus a margin ranging
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
HEALTHEQUITY, INC. amended Amendment No. 1 to Credit Agreement with JPMorgan Chase Bank, N.A. valued at Amended interest rate provisions based on LIBOR to Term SOFR; borrowings bear interest at Term SOFR (effective 2023-06-01).
- Action
- amendment
- Agreement
- credit facility
- Counterparty
- JPMorgan Chase Bank, N.A.
- Value
- Amended interest rate provisions based on LIBOR to Term SOFR; borrowings bear interest at Term SOFR
- Effective
- 2023-06-01
Exact text from the filing
On June 1, 2023, HealthEquity, Inc. (the “Company”) entered into an Amendment No. 1 to Credit Agreement (“Amendment No. 1”), which amends that certain Credit Agreement, dated as of October 8, 2021 (the “Credit Agreement”), among the Company, as borrower, each lender from time to time party thereto, JPMorgan Chase Bank, N.A., as administrative agent and the Swing Line Lender (as defined therein), and each L/C Issuer (as defined therein) party thereto.
View on SEC.gov